Company Novartis AG Nyse

Equities

NVS

US66987V1098

Pharmaceuticals

Market Closed - Nyse 04:00:02 2024-03-28 pm EDT 5-day change 1st Jan Change
96.73 USD +0.89% Intraday chart for Novartis AG +0.68% -4.20%

Business Summary

Novartis AG is one of the world's leaders in the design, manufacturing, and marketing of pharmaceutical products. Net sales (excluding discontinued operations) break down by therapeutic area as follows:

- oncology (29.9%);

- immunology (17.2%);

- cardiovascular, renal and metabolic diseases (14.1%);

- neuroscience (8.9%).

The remaining net sales (29.9%) are from contract manufacturing of pharmaceutical products.

At the end of 2023, Novartis AG had 33 production sites worldwide.

Net sales are distributed geographically as follows: Europe (33%), the United States (39.5%), Asia/Africa/Australasia (20.5%), Canada and Latin America (7%).

Number of employees: 76,057

Sales per Business

CHF in Million2022Weight2023Weight Delta
Established Brands
30.0 %
- - 12,238 30.0 % -
Oncology
29.9 %
- - 12,213 29.9 % -
Immunology
17.2 %
- - 7,008 17.2 % -
Cardiovascular, Renal and Metabolic
14.1 %
- - 5,743 14.1 % -
Neuroscience
8.9 %
- - 3,633 8.9 % -

Sales per region

CHF in Million2022Weight2023Weight Delta
United States
39.5 %
16,860 34.9 % 16,139 39.5 % -4.28%
Europe
18.9 %
10,469 21.7 % 7,704 18.9 % -26.41%
Asia/Africa/Australasia
9.1 %
4,975 10.3 % 3,700 9.1 % -25.63%
Germany
7.4 %
4,086 8.5 % 3,026 7.4 % -25.94%
China
7.2 %
2,987 6.2 % 2,936 7.2 % -1.73%
Canada and Latin America
7.0 %
3,709 7.7 % 2,854 7.0 % -23.04%
Japan
4.2 %
2,106 4.4 % 1,729 4.2 % -17.90%
France
3.8 %
2,156 4.5 % 1,572 3.8 % -27.09%
Switzerland
2.9 %
926 1.9 % 1,175 2.9 % +26.88%

Managers

Managers TitleAgeSince
Chief Executive Officer 48 04-12-31
Director of Finance/CFO 59 02-12-31
Chief Tech/Sci/R&D Officer 62 22-05-15
Chief Operating Officer 57 17-03-31
Compliance Officer 56 18-11-30
Public Communications Contact 63 03-12-31
Corporate Officer/Principal - 13-07-31
Comptroller/Controller/Auditor 61 22-04-30
Corporate Officer/Principal - -
Human Resources Officer 56 21-08-31

Members of the board

Members of the board TitleAgeSince
Director/Board Member 62 12-12-31
Director/Board Member 65 20-02-27
Chairman 68 12-12-31
Director/Board Member 60 23-03-06
Director/Board Member 63 20-02-27
Director/Board Member 59 15-12-31
Director/Board Member 65 12-12-31
Director/Board Member 66 14-12-31
Director/Board Member 68 19-02-27
Director/Board Member 63 17-02-27

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 2,277,477,752 1,866,336,959 ( 81.95 %) 233,443,766 ( 10.25 %) 81.95 %

Shareholders

NameEquities%Valuation
145,083,991 6.370 % 14 745 M $
Sandoz Family Foundation
3.914 %
89,135,960 3.914 % 9 059 M $
UBS Asset Management Switzerland AG
3.003 %
68,391,910 3.003 % 6 951 M $
Universal-Investment-Gesellschaft mbH (Invt Mgmt)
0.2895 %
6,593,896 0.2895 % 670 M $
State Street Global Advisors Ltd.
0.2014 %
4,586,765 0.2014 % 466 M $
UBS AG (Investment Management)
0.1713 %
3,902,170 0.1713 % 397 M $
La Mondiale SAM (Investment Portfolio)
0.1707 %
3,888,630 0.1707 % 395 M $
MFS International (UK) Ltd.
0.1701 %
3,873,030 0.1701 % 394 M $
MFS International Singapore Pte. Ltd.
0.1672 %
3,806,964 0.1672 % 387 M $
Union Investment Privatfonds GmbH
0.1595 %
3,632,402 0.1595 % 369 M $
NameEquities%Valuation
Dodge & Cox
0.5781 %
13,165,538 0.5781 % 1 329 M $
PRIMECAP Management Co.
0.5667 %
12,905,697 0.5667 % 1 303 M $
Eaton Vance Management
0.3114 %
7,092,253 0.3114 % 716 M $
Dimensional Fund Advisors LP
0.2669 %
6,078,175 0.2669 % 614 M $
Loomis, Sayles & Co. LP
0.2639 %
6,009,900 0.2639 % 607 M $
Fiduciary Trust Company International
0.2598 %
5,915,750 0.2598 % 597 M $
U.S. Trust Company of Delaware
0.2309 %
5,258,331 0.2309 % 531 M $
Wellington Management Co. LLP
0.2084 %
4,746,599 0.2084 % 479 M $
Wells Fargo Bank NA
0.1754 %
3,994,934 0.1754 % 403 M $
The Ayco Co. LP
0.1553 %
3,535,902 0.1553 % 357 M $
NameEquities%Valuation
LUKB Expert Fondsleitung AG
-
64,694 - 7 M $
ATP Fondsmaeglerselskab A/S
-
46,082 - 5 M $
Swiss Rock Asset Management AG
-
19,614 - 2 M $
Niederer & Partners AG
-
5,300 - 538 457 $
JPMorgan Asset Management (China) Co Ltd.
-
2,652 - 269 432 $
Liontrust Portfolio Management Ltd.
-
474 - 48 156 $

Holdings

NameEquities%Valuation
145,083,991 6.37% 14,744,836,677 $
18,524,209 4.30% 577,678,384 $
17,450,680 70.68% 198,486,303 $
12,307,692 8.15% 29,292,307 $
2,642,762 6.55% 26,797,607 $
5,908,089 6.18% 23,396,032 $
1,713,521 4.68% 20,390,900 $
1,739,130 4.78% 7,712,572 $
413,577 6.51% 7,651,175 $
4,336,759 3.27% 1,561,233 $

Company contact information

Novartis AG

Lichtstrasse 35

4056, Basel

+41 61 324 1111

http://www.novartis.com
address Novartis AG(NVS)

Group companies

NameCategory and Sector
Pharmaceuticals: Major
Investment Managers
Pharmaceuticals: Major
Investment Managers
Pharmaceuticals: Major
Finance/Rental/Leasing
Novartis Finance SA
Finance/Rental/Leasing
Pharmaceuticals: Major
Pharmaceuticals: Major

Sales per Business

Sales per region

Trading Rating
Investor Rating
ESG Refinitiv
-
More Ratings
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
19
Last Close Price
97.01 USD
Average target price
107.9 USD
Spread / Average Target
+11.25%
Consensus